Kumayambiriro kwa mliriwu, Foregene adasamalira kwambiri, ndipo adakonza kafukufuku wasayansi nthawi yomweyo kuti akhazikitse ndalama mu R&D ya zida zatsopano zozindikirira ma nucleic acid.Kutengera zaka zambiri zakugwa kwaukadaulo komanso luso, gululo linagwiritsa ntchito ukadaulo wa patent wa Direct PCR kupanga mwachangu zida zatsopano zodziwira za coronavirus (SARS-CoV-2).

Zidazi siziyenera kutulutsa nucleic acid kuchokera pachitsanzocho, ndipo zimatha kuzindikira nthawi yeniyeni ya fulorosenti yochulukirachulukira ya PCR pambuyo pokonza kutulutsa kwa nucleic acid, komwe kumathandizira kuyeserera kotopetsa kusanachitike, kumapewa kutayika kwa nucleic acid yachitsanzo, ndikupeza zotsatira zoyesa mkati mwa ola la 1, makamaka oyenera kuyesa mwachangu.

Ndi kufalikira kwa mliri wapadziko lonse lapansi, monga membala wamakampani aku China a IVD, Foregene imagwiranso ntchito yofunika kwambiri yolimbana ndi mliri wapadziko lonse lapansi.Chidacho chinapeza satifiketi ya EU CE kumapeto kwa Marichi.Pakati pa mwezi wa April, Forgene pamodzi ndi BIOWALKER PTE LTD, Singapore, adadutsa Health Sciences Authority (HSA) ya Singapore (Health Sciences Authority, HSA), kutanthauza kutiForegene atha kupereka thandizo kumayiko akunja omwe amafunikira zida zopewera ma virus.

M'tsogolomu, Foregene azitsatira malingaliro okhwima asayansi ndikupitilizabe kupereka zogulitsa ndi ntchito zogwira ntchito bwino kwambiri komanso zodalirika pamisika iwiri yayikulu yofufuza ndi kuzindikira zasayansi.